Effects of sub-chronic combined treatment with pergolide and caffeine on contralateral rotational behavior in unilateral 6-hydroxydopamine-denervated rats (Q73897595)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 June 2000

Language	Label	Description	Also known as
English	Effects of sub-chronic combined treatment with pergolide and caffeine on contralateral rotational behavior in unilateral 6-hydroxydopamine-denervated rats	scientific article published on 01 June 2000

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10854593%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Effects of sub-chronic combined treatment with pergolide and caffeine on contralateral rotational behavior in unilateral 6-hydroxydopamine-denervated rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10854593%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

G Prat

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10854593%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

P Robledo

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10854593%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

A Rubio

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10854593%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Barbanoj

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10854593%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

F Jané

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10854593%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Casas

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10854593%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 June 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10854593%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

number of pages

4

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10854593%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

868

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10854593%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10854593%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

376-379

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10854593%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Rotational behaviour induced by theophylline in 6-OHDA nigrostriatal denervated rats is dependent on the supersensitivity of striatal dopaminergic receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902361-1

7 January 2021

Relationship between rotational behaviour induced by apomorphine and caffeine in rats with unilateral lesion of the nigrostriatal pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902361-1

7 January 2021

Repeated co-administration of caffeine and bromocriptine prevents tolerance to the effects of caffeine in the turning behavior animal model

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902361-1

7 January 2021

Scopolamine prevents tolerance to the effects of caffeine on rotational behavior in 6-hydroxydopamine-denervated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902361-1

7 January 2021

Rotational behavior in dopamine nigrostriatal denervated rats: effects of a wide range of time intervals between apomorphine administrations

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902361-1

7 January 2021

Caffeine tolerance and choice in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902361-1

7 January 2021

Adenosine-dopamine interactions in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902361-1

7 January 2021

Pharmacologic specificity of tolerance to caffeine-induced stimulation of locomotor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902361-1

7 January 2021

Adenosine actions and adenosine receptors after 1 week treatment with caffeine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902361-1

7 January 2021

Pergolide: A dopamine agonist at both D1 and D2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902361-1

7 January 2021

Effects of chronic administration of caffeine on adenosine A1 and A2 receptors in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902361-1

7 January 2021

Caffeine produces contralateral rotation in rats with unilateral dopamine denervation: comparisons with apomorphine-induced responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902361-1

7 January 2021

The effect of theophylline on parkinsonian symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902361-1

7 January 2021

A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902361-1

7 January 2021

Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902361-1

7 January 2021

Development of tolerance to dopaminergic stimulating effect of theophylline in mice with unilateral striatal 6-hydroxydopamine lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902361-1

7 January 2021

Identifiers

10.1016/S0006-8993(00)02361-1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10854593%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10854593%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73897595&oldid=1950410800"